Noxxon Pharma NV

11/22/2021 | Press release | Distributed by Public on 11/22/2021 00:50

NOXXON: New Phase 1/2 data on NOX-A12 & radiotherapy combination in brain cancer presented at the Society for Neuro-Oncology Annual Meeting 2021